Scipher Medicine announced that Galapagos (NASDAQ: GLPG) has exercised its option to in-license novel drug targets for inflammatory bowel disease (IBD) discovered by Scipher's...
While paid vacation days are a sought-after benefit, some employers are taking it a step further and giving workers money to help offset the cost of their trips
Investing.com - Galapagos ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Galapagos ADR announced earnings per...
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Buy | Neutral | Strong Sell | Strong Sell |
| Summary | Strong Sell | Neutral | Neutral | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.245 | 0.245 | 0.235 | +0.010 | +4.26% | 237.42K | Sydney | |||
| 0.15 | 0.155 | 0.145 | 0.000 | 0.00% | 5.29M | Sydney | |||
| 0.172 | 0.175 | 0.17 | +0.003 | +1.47% | 237.03K | Sydney | |||
| 14.88 | 14.88 | 14.61 | +0.42 | +2.90% | 822.85K | Sydney | |||
| 5.46 | 5.50 | 5.40 | +0.05 | +0.92% | 4.39M | Sydney | |||
| 0.42 | 0.425 | 0.415 | 0.000 | 0.00% | 588.06K | Sydney | |||
| 0.029 | 0.03 | 0.028 | +0.001 | +3.57% | 12.35M | Sydney | |||
| 0.097 | 0.105 | 0.097 | -0.008 | -7.62% | 892.47K | Sydney | |||
| 1.19 | 1.21 | 1.175 | +0.035 | +3.03% | 956.38K | Sydney | |||
| 23.10 | 23.14 | 22.50 | +0.93 | +4.19% | 345.23K | Sydney | |||
| 6.69 | 6.70 | 6.69 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.26 | 0.285 | 0.26 | -0.010 | -3.70% | 299.80K | Sydney | |||
| 1.48 | 1.50 | 1.45 | +0.05 | +3.51% | 1.42M | Sydney | |||
| 0.026 | 0.026 | 0.026 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.19 | 0.19 | 0.185 | 0.000 | 0.00% | 0.00 | Sydney |